Publication | Closed Access

Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial

ObesityMetabolic SyndromeNon-pharmacological InterventionDiabetes ManagementHealth PolicyGlobal HealthDiabetesClinical TrialsType 2Step 6PharmacotherapyEast Asian PopulationDiabetes MellitusMedicineHealth Sciences